Sangamo Therapeutics (0R1D) Share Forecast & Price Target
0R1D Analyst Ratings
There are no analyst ratings in the last 3 months.
0R1D Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Best Analysts Covering Sangamo Therapeutics
Copying xAi Biotechnology's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of -7.93% per trade.
Copying xAi Biotechnology's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -7.93% per trade.
Copying xAi Biotechnology's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of -7.93% per trade.
0R1D Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 2 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 6 | 4 | 2 | 0 | 0 |
In the current month, 0R1D has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0R1D average Analyst price target in the past 3 months is ―.
0R1D Financial Forecast
0R1D Sales Forecast
Next quarter’s sales forecast for 0R1D is $0 with a range of ― to ―. The previous quarter’s sales results were $1.44M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.